SNNU.F Stock Overview
Develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
Smith & Nephew plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£12.25 |
| 52 Week High | UK£15.70 |
| 52 Week Low | UK£11.49 |
| Beta | 0.70 |
| 11 Month Change | -14.63% |
| 3 Month Change | -18.33% |
| 1 Year Change | -7.69% |
| 33 Year Change | -24.29% |
| 5 Year Change | -45.37% |
| Change since IPO | 105.88% |
Recent News & Updates
Recent updates
Shareholder Returns
| SNNU.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0.6% | 1.5% | 2.2% |
| 1Y | -7.7% | 20.8% | 31.6% |
Return vs Industry: SNNU.F underperformed the US Medical Equipment industry which returned 20.9% over the past year.
Return vs Market: SNNU.F underperformed the US Market which returned 31.7% over the past year.
Price Volatility
| SNNU.F volatility | |
|---|---|
| SNNU.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: SNNU.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine SNNU.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1856 | 18,000 | Deepak Nath | www.smith-nephew.com |
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
Smith & Nephew plc Fundamentals Summary
| SNNU.F fundamental statistics | |
|---|---|
| Market cap | US$10.78b |
| Earnings (TTM) | US$305.00m |
| Revenue (TTM) | US$5.64b |
35.4x
P/E Ratio1.9x
P/S RatioIs SNNU.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SNNU.F income statement (TTM) | |
|---|---|
| Revenue | US$5.64b |
| Cost of Revenue | US$1.67b |
| Gross Profit | US$3.97b |
| Other Expenses | US$3.66b |
| Earnings | US$305.00m |
Last Reported Earnings
Jun 29, 2024
Next Earnings Date
Feb 25, 2025
| Earnings per share (EPS) | 0.35 |
| Gross Margin | 70.33% |
| Net Profit Margin | 5.41% |
| Debt/Equity Ratio | 66.7% |
How did SNNU.F perform over the long term?
See historical performance and comparison